ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,613, issued on April 21, was assigned to InflaRx GmbH (Jena, Germany).
"Humanized anti-C5a antibodies" was invented by Renfeng Guo (Ann Arbor, Mich.) and Niels C. Riedemann (Jena, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies that specifically bind to a conformational epitope of human C5a. The invention particularly relates to humanized anti-C5a antibodies. The antibodies described herein are useful as active agents in pharmaceutical compositions. The antibodies and pharmaceutical compositions are especially useful for the treatment and prevention of diseases or disorders involving pathological C...